Three plenary sessions over three days will highlight the latest discoveries, cutting-edge technology, emerging trends, and new clinical approaches for rheumatologic disease. The goal of all of the included studies is to improve upon the work being done in the field on behalf of patients,…

Carol Langford, MD, MHS, will discuss cutting-edge advancements in clinical science from the past year, including new approaches to rheumatoid arthritis, lupus, spondyloarthritis, and myositis treatment. John Varga, MD, will discuss emerging developments in basic science, including single-cell RNA sequencing and other high-throughput technologies.

The convergence between rheumatology and infectious disease presented by COVID-19 continues to surprise patients, clinicians, researchers, industry, regulators, and other stakeholders. Stephen Saw, PharmD, BCIDP, is among the experts who will discuss the ongoing implications of this disease on rheumatology.

Evidence-based solutions to overcoming gaps in health outcomes will require a commitment by clinicians and health systems to measure disparities so the data can be stratified by demographic factors and other social determinants of health, said Jon Burnham, MD, MSCE.

Targeting program directors, division directors, and others who provide education to medical students, residents, or fellows, the Educators Forum is a unique opportunity to focus on how ACR initiatives impact this community, along with discussions on timely educational concepts, designs, and execution strategies, said moderator…